Matthew J. Ellis

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Papers

Driven by 79 papers — median percentile 0. Top paper: “Proteogenomics connects somatic mutations to signalling in breast cancer”.

Proteogenomics connects somatic mutations to signalling in breast cancer

Nature(2016)10.1038/nature18003

N/A

12.7DataRank · unranked

1777 citations

Philipp Mertins, D. R. Mani, Kelly V. Ruggles, Michael A. Gillette, Karl R. Clauser +31 more

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Cell(2020)10.1016/j.cell.2020.10.036

N/A

8.1DataRank · unranked

565 citations

Eric J. Jaehnig, Shankha Satpathy, Lili M. Blumenberg, Alla Y. Karpova, Meenakshi Anurag +85 more

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cell(2021)10.1016/j.cell.2021.08.023

N/A

7.9DataRank · unranked

606 citations

Chen Huang, Daniel Cui Zhou, Yingwei Hu, T. Mamie Lih, Sara R. Savage +95 more

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms14864

N/A

4.9DataRank · unranked

155 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

Cell(2023)10.1016/j.cell.2023.07.013

N/A

3.5DataRank · unranked

197 citations

Shankara Anand, Yo Akiyama, Tomer M. Yaron, Yizhe Song, Jared L. Johnson +90 more

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0200

N/A

2.5DataRank · unranked

140 citations

Eric J. Jaehnig, Karsten Krug, Jonathan T. Lei, Erik J. Bergstrom, Beom-Jun Kim +34 more

Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin

Cancer Cell(2023)10.1016/j.ccell.2023.07.013

N/A

1.8DataRank · unranked

107 citations

Rita Jui-Hsien Lu, Reyka G. Jayasinghe, Steven M. Foltz, Eduard Porta‐Pardo, Yifat Geffen +95 more

Pan-cancer proteogenomics characterization of tumor immunity

Cell(2024)10.1016/j.cell.2024.01.027

N/A

1.7DataRank · unranked

91 citations

Weiping Ma, Tomer M. Yaron, Francesca Pia Caruso, Nicole Tignor, Joshua M. Wang +95 more

Breast tumors educate the proteome of stromal tissue in an individualized but coordinated manner

Science Signaling(2017)10.1126/scisignal.aam8065

N/A

1.2DataRank · unranked

24 citations

Arshag D. Mooradian, Petra Erdmann-Gilmore, Qiang Zhang, Rosa Viner, Sherri R. Davies +12 more

Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06307-3

N/A

1.1DataRank · unranked

35 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancer

Nature Communications(2021)10.1038/s41467-021-23271-0

N/A

0.995DataRank · unranked

23 citations

Sinem Şeker, Vaishnavi Devarakonda, Aloran Mazumder, Rashi Kalra, Ching Hui Chen +6 more

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer

Nature Communications(2024)10.1038/s41467-024-45132-2

N/A

0.988DataRank · unranked

35 citations

Karthik Reddy Kami Reddy, Yang Yuntao, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey E. Dobrolecki +19 more

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa201

N/A

0.982DataRank · unranked

694 citations

Samuel Leung, David L. Rimm, Andrew Dodson, Balázs Ács, Sunil Badve +17 more

Patterns and functional implications of rare germline variants across 12 cancer types

Nature Communications(2015)10.1038/ncomms10086

N/A

0.862DataRank · unranked

312 citations

Mingchao Xie, Michael C. Wendl, Jiayin Wang, Michael D. McLellan, Mark D. M. Leiserson +40 more

Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101173

N/A

0.843DataRank · unranked

33 citations

Runyu Hong, Elizabeth G. Demicco, Jimin Tan, Rossana Lazcano, André L. Moreira +95 more

Correction: Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Nature Communications(2017)10.1038/ncomms15479

N/A

0.843DataRank · unranked

11 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

iScience(2022)10.1016/j.isci.2022.105799

N/A

0.830DataRank · unranked

35 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram Srinivasan +25 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

JAMA Oncology(2024)10.1001/jamaoncol.2023.6038

N/A

0.819DataRank · unranked

21 citations

Vera J. Suman, Souzan Sanati, Kiran Vij, Meenakshi Anurag, A. Marilyn Leitch +25 more

Microscaled proteogenomic methods for precision oncology

Nature Communications(2020)10.1038/s41467-020-14381-2

N/A

0.722DataRank · unranked

122 citations

Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan +28 more

Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.02.003

N/A

0.702DataRank · unranked

107 citations

Meenakshi Anurag, Jonathan T. Lei, Jin Cao, Purba Singh, Jianheng Peng +26 more

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

UNC Libraries(2020)10.17615/0xdg-yq72

N/A

0.552DataRank · unranked

6 citations

Shunqiang Li, Philipp Mertins, Song Cao, Harsha P. Gunawardena, Kelly V. Ruggles +40 more

Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

Cancers(2020)10.3390/cancers12123857

N/A

0.396DataRank · unranked

13 citations

Tina Primeau, Jingqin Luo, Cynthia Zhang, Hua Sun, Jeremy Hoog +10 more

Precision proteogenomics reveals pan-cancer impact of germline variants

Cell(2025)10.1016/j.cell.2025.03.026

N/A

0.341DataRank · unranked

8 citations

Nadezhda V. Terekhanova, Kathleen J. Imbach, Karl R. Clauser, Myvizhi Esai Selvan, Isabel Mendizabal +132 more

Proteogenomics connects somatic mutations to signalling in breast cancer

UNC Libraries(2020)10.17615/mepw-5x28

N/A

0.269DataRank · unranked

5 citations

Mani, Kelly V. Ruggles, Michael A. Gillette, Karl R. Clauser, Pei Wang +31 more

Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer

Cancer Discovery(2025)10.1158/2159-8290.cd-23-1173

N/A

0.208DataRank · unranked

3 citations

Shankha Satpathy, Karsten Krug, Jitendra K. Meena, Nivetha Ramesh Babu, Cheyenne Calderon +51 more

System Interventions to Achieve Early and Equitable Kidney Transplants (STEPS): Protocol for STEPS, a randomized comparative effectiveness clinical trial

Contemporary Clinical Trials(2025)10.1016/j.cct.2025.107911

N/A

0.165DataRank · unranked

2 citations

Patti L. Ephraim, Tariq Shafi, Jamie Green, Teri Browne, Tara S. Strigo +14 more

Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer

Cell(2021)10.1016/j.cell.2020.12.031

N/A

0DataRank · unranked

227 citations

Jarey H. Wang, Fade Gong, William Wu, Nicholas J. Neill, Ik Sun Kim +32 more

The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells

Developmental Cell(2021)10.1016/j.devcel.2021.03.008

N/A

0DataRank · unranked

119 citations

Weijie Zhang, Jingyuan Hu, Zhan Xu, Hai Wang, Poonam Sarkar +21 more

Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer

Cancer Research(2021)10.1158/0008-5472.can-21-1256

N/A

0DataRank · unranked

24 citations

Meenakshi Anurag, Jonathan T. Lei, Beom‐Jun Kim, Purba Singh, Sinem Şeker +16 more

Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-2961

N/A

0DataRank · unranked

12 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jin-Ah Kim +13 more

A Network Approach to Identify Biomarkers of Differential Chemotherapy Response Using Patient-Derived Xenografts of Triple-Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.20.457116

N/A

0DataRank · unranked

5 citations

Lacey E. Dobrolecki, Lillian Ashmore, Alaina Lewis, Christina Sallas, Ramakrishnan Rajaram +19 more

Immunogenomic Profiling and Pathological Response Results From a Clinical Trial of Docetaxel and Carboplatin in Triple Negative Breast Cancer

Research Square(2021)10.21203/rs.3.rs-420931/v1

N/A

0DataRank · unranked

1 citations

Ina Chen, Jingqin Luo, Mothaffar F. Rimawi, Ian S. Hagemann, Bryan Fisk +29 more

Evaluation of sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy (NET) and subsequent prognosis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.580

N/A

0DataRank · unranked

0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Poziotinib Inhibits HER2-Mutant–Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-3106

N/A

0DataRank · unranked

17 citations

Ching Hui Chen, Junkai Wang, Ahmad Bin Salam, Lacey E. Dobrolecki, Alaina Lewis +9 more

LINC00355 regulates p27KIP expression by binding to MENIN to induce proliferation in late-stage relapse breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00412-2

N/A

0DataRank · unranked

11 citations

Prasanth K. Thunuguntla, Kyla Gelev, Cynthia Y. Tang, Emily B. Rozycki, Alexander L. Miller +11 more

Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors

Science(2023)10.1126/science.abn4180

N/A

0DataRank · unranked

113 citations

Xuan Lu, Jin Cao, Qin Luo, Yao Ding, Fanglue Peng +34 more

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer

Annals of Surgical Oncology(2023)10.1245/s10434-022-12972-5

N/A

0DataRank · unranked

21 citations

Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey +4 more

Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer

Cancer Research(2023)10.1158/0008-5472.can-22-3484

N/A

0DataRank · unranked

12 citations

Beom-Jun Kim, Meenakshi Anurag, Jonathan T. Lei, Meggie N. Young, Matthew V. Holt +11 more

Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0044

N/A

0DataRank · unranked

8 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0501

N/A

0DataRank · unranked

2 citations

Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt +7 more

Association of Age and Gender With Concerns About Live Donor Kidney Transplantation Among Black Individuals

Transplantation Proceedings(2023)10.1016/j.transproceed.2023.10.001

N/A

0DataRank · unranked

1 citations

Patti L. Ephraim, Clemontina A. Davenport, Lisa M. McElroy, Dinushika Mohottige, Nicole DePasquale +8 more

Data from PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer

(2023)10.1158/0008-5472.c.6499523.v1

N/A

0DataRank · unranked

0 citations

Chanpheng Phommaly, Yu Tao, Jeremy Hoog, Jingqin Luo, Charles M. Perou +12 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031)

(2023)10.1158/1078-0432.c.6532350.v1

Top 100%

0DataRank

Top 100%0 citations

Lili Du, Tanya L. Hoskin, Meenakshi Anurag, X. Cynthia, Isabelle Bedrosian +4 more

Data from Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer

(2023)10.1158/1078-0432.c.6531045

N/A

0DataRank · unranked

0 citations

Jamunarani Veeraraghavan, Chia-Chia Liu, Xixi Cao, Lanfang Qin, Jinah Kim +13 more

Data from Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

(2023)10.1158/2767-9764.c.6752049

N/A

0DataRank · unranked

0 citations

Alexander B. Saltzman, Eric J. Jaehnig, Jonathan T. Lei, Anna Malovannaya, Matthew V. Holt +7 more

Data from Proteogenomic Approaches for the Identification of NF1/Neurofibromin-depleted Estrogen Receptor–positive Breast Cancers for Targeted Treatment

(2023)10.1158/2767-9764.c.6729507.v2

N/A

0DataRank · unranked

0 citations

Ze-Yi Zheng, Jonathan T. Lei, Matthew V. Holt, Anran Chen, Jianheng Peng +20 more

PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0564

N/A

0DataRank · unranked

22 citations

Beom-Jun Kim, Aparna Mitra, Craig T. Vollert, Jonathan T. Lei, Diana Fandino +18 more

De novo belatacept does not reduce the rate of skin cancer in renal transplant recipients compared to standard therapy

Journal of the American Academy of Dermatology(2024)10.1016/j.jaad.2024.05.068

N/A

0DataRank · unranked

9 citations

Winston Liu, Christopher Stamey, Meenal Kheterpal, Sarah A. Myers, Matthew J. Ellis +4 more

Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.06.037

N/A

0DataRank · unranked

2 citations

Rachna Shah, Andrew Bell, Niamh McDermott, Xin Pei, Pier Selenica +11 more

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor–Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination

UNC Libraries(2024)10.17615/41px-cd59

N/A

0DataRank · unranked

1 citations

Travis Dockter, Amy Tiersten, Matthew J. Ellis, Kelly K. Hunt, Wajeeha Razaq +25 more

Microscaled proteogenomic methods for precision oncology

UNC Libraries(2024)10.17615/rb11-7v56

N/A

0DataRank · unranked

0 citations

B Zhang, F. O. Ademuyiwa, Prashant R. Singh, Charles M. Perou, Alexander B. Saltzman +28 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416119.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancer

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102255

N/A

0DataRank · unranked

1 citations

Yongchao Dou, Meggie N. Young, Alexander B. Saltzman, Meenakshi Anurag, Jonathan T. Lei +20 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416128.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416122

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416116

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416134

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 1 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416131.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 5 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416119

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary tables 1 and 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416116.v1

Top 100%

0DataRank

Top 100%0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Data from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.c.6509465

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416140

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 2 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

(2023)10.1158/0008-5472.22416128

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary File 4 from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416122.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Extended Methods from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416140.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Supplementary Figures from Mass Spectrometry–Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/0008-5472.22416134.v1

N/A

0DataRank · unranked

0 citations

Sandeep Rajput, Shunqiang Li, Kelly V. Ruggles, Arshag D. Mooradian, Philipp Mertins +28 more

Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa148

N/A

0DataRank · unranked

115 citations

Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer +23 more

Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States

American Journal of Transplantation(2020)10.1111/ajt.15791

N/A

0DataRank · unranked

98 citations

Laura McPherson, Zhensheng Wang, Laura Plantinga, Sudeshna Paul, Matthew J. Ellis +8 more

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

JCI Insight(2020)10.1172/jci.insight.137571

N/A

0DataRank · unranked

45 citations

James N. Ingle, Tanda M. Dudenkov, Krishna R. Kalari, Erin E. Carlson, Jie Na +12 more

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models

UNC Libraries(2020)10.17615/zy2g-ye61

N/A

0DataRank · unranked

19 citations

Christine E. Ryan, Aleix Prat, Zhanfang Guo, Matthew J. Ellis, W. Timothy Schaiff +8 more

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3091

N/A

0DataRank · unranked

41 citations

Junmei Cairns, Vera J. Suman, Lois E. Shepherd, Peter A. Fasching, Tanya L. Hoskin +19 more

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

British Journal of Cancer(2020)10.1038/s41416-020-01174-z

N/A

0DataRank · unranked

27 citations

Guowei Gu, Amanda Beyer, Sarah K. Herzog, David G. Edwards, Hangqing Lin +12 more

Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction

Digital Commons@Becker (Washington University School of Medicine)(2020)10.17615/b898-yw29

N/A

0DataRank · unranked

1 citations

Amanda G. Paulovich, R. Reid Townsend, Matthew J. Ellis, Zihao Ma, Christopher R. Kinsinger +15 more

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Digital Commons@Becker (Washington University School of Medicine)(2020)10.17615/6e7v-pv95

N/A

0DataRank · unranked

1 citations

Tracy Lively, John A. Olson, Robert J. Gray, Virginia Kaklamani, Della Makower +26 more

QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues

UNC Libraries(2020)10.17615/gcj3-5y88

N/A

0DataRank · unranked

0 citations

John A. Wrobel, Shunqiang Li, Ling Xie, Sherri R. Davies, Harsha P. Gunawardena +4 more

Chemotherapy-related amenorrhea after adjuvant paclitaxel–trastuzumab (APT trial)

UNC Libraries(2020)10.17615/e33z-ag80

N/A

0DataRank · unranked

0 citations

Harold J. Burstein, Lisa A. Carey, Antonio C. Wolff, Sara M. Tolaney, P. Kelly Marcom +15 more

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women

UNC Libraries(2020)10.17615/2dy4-8b47

N/A

0DataRank · unranked

0 citations

Anita K. Dunbier, H Anderson, Elizabeth Folkerd, Charles M. Perou, Roger A’Hern +9 more

Matthew J. Ellis

Indexed papers

Top data-sharing exemplar

Papers